SNGX (Soligenix, Inc.) Pangali Forward P/E

Logo perusahaan publik Soligenix (SNGX)

Soligenix, Inc. (SNGX) strictly adheres to environmental regulations by implementing energy conservation and emission filtration. After evaluating the company's future P/E ratio on GURU.Markets, we find that 0.00 determines the latest valuation metric. This price action is based on lymphoma therapy test results and government grants for vaccines, as well as the stability of a compact team of experts incentivized by stock options.

Rasio rega marang bathi mangsa ngarep: Soligenix, Inc. (SNGX) kanggo 04.07.2022 - 12.11.2026

Ringkesan rincian data analitis BioPharma Bio (SNGX)

- rega saiki lan proyeksi nilai saham:
Kutipan saham Soligenix, Inc.|SNGX - Konsensus nilai wajar
- indikator valuasi pasar bisnis:
Kapitalisasi pasar Soligenix Inc|SNGX - Rega Tumbas Perusahaan
- informasi kapitalisasi buku:
Aset Bersih saben Siji Saham Soligenix|SNGX - Kapitalisasi Akuntansi|Rasio Kapitalisasi Pasar marang Nilai Buku soligenix.com|SNGX - Nilai Total Aset Perusahaan
- rincian utang lan likuiditas:
Total Utang marang Modal Soligenix, Inc.|SNGX - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang modal Soligenix, Inc.|SNGX - Gunggung utang perusahaan|Utang marang nilai buku Soligenix Inc|SNGX - Gedhene kewajiban jangka dawa|Utang jangka cendhak perusahaan Soligenix|Likuiditas cepet soligenix.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
SNGX - Penghasilan resik perusahaan|Bathi sing dikarepake Soligenix, Inc.|SNGX - Pangali rega marang bathi|Rega marang bathi mangsa ngarep Soligenix, Inc.|SNGX - Kapitalisasi marang bathi resik kanthi nimbang wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Soligenix Inc|SNGX - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Soligenix|SNGX - Bathi resik saben siji saham sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan soligenix.com|SNGX - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Soligenix, Inc.
Analisis fundamental perusahaan:Soligenix SNGX
Produk merek BioPharma Bio

The forward P/E determines the ratio of the current market value of Soligenix, Inc. (SNGX) to the projected net income for the following year, measuring market expectations regarding the asset's future returns. By analyzing the forward P/E chart for Soligenix, Inc. (SNGX), an investor can see the valuation's sensitivity to R&D cycles, which is critical for a startup developing a pipeline of orphan drugs aimed at accelerated market entry.

Pesaing wigati

Prakiraan rega marang bathi SMMT (Summit Therapeutics Inc.)|MRNA (Moderna Inc) - Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E PCVX (Vaxcyte Corp)|Kapitalisasi marang proyeksi bathi Tarsus Corp (TARS)|CRMD - Rega marang bathi mangsa ngarep|MCRB (serestherapeutics.com) - Rasio rega marang bathi mangsa ngarep|SPRO: Pangali Forward P/E|Rasio rega marang bathi sing dikarepake SCYX (SCYNEXIS)|ANTX (AN2 Therapeutics Inc) - Pangali Forward P/E|Rasio prakiraan rega marang bathi PolyPid Limited PYPD|Pangali Forward P/E LSB|Prakiraan rega marang bathi iterumtx.com ITRM|BiomX - Prakiraan rega marang bathi|Rasio kapitalisasi marang bathi mangsa ngarep SXTP (60 Degrees Pharmaceuticals Inc.)|Oragenics - Pangali Forward P/E|Kapitalisasi marang proyeksi bathi OpGen Corporation OPGN